To confirm equal protein loading per sample, we used antibody anti-calnexin or anti-GAPDH. Detection of specific proteins was performed by enhanced chemioluminescence reagent (Western Lightning ECL Pro, Perkin Elmer). Quantitative measurement of immunoreactive band intensities was performed by densitometry analysis using the Scion Image software (Scion Corporation, Frederick, MD, USA). Only for AMPK inhibitor experiments and CaMKII, immunoreactive bands were visualized by Uvitec Alliance LD9 gel imaging system (Uvitec, Cambridge, UK).
Data were then presented as ratio between treated cells and control.